rituximab monotherapy

Related by string. * Rituximab : rituximab refractory follicular . refractory rituximab naive . rituximab Rituxan . rituximab Rituxan R . MabThera rituximab . rituximab Rituxan ® . Rituxan rituximab / Monotherapy : Lucentis monotherapy . methotrexate monotherapy . Tysabri monotherapy . artemisinin monotherapy . REMICADE monotherapy . metformin monotherapy . infliximab monotherapy * *

Related by context. Frequent words. (Click for all words.) 63 interferon therapy 62 mg kg dose 61 androgen deprivation 59 virologic response 59 hypercalcemia 59 virologic 58 decitabine 58 neutralizing antibody 58 complete cytogenetic 58 chlorambucil 58 dasatinib 58 chemoradiotherapy 58 antibody titers 58 epithelial ovarian cancer 57 mRCC 57 HSCT 57 plus dexamethasone 57 nonresponders 57 APOPTONE 57 bleomycin 57 biochemical recurrence 57 PCa 57 virologic failure 57 lupus nephritis 57 breast carcinoma 57 complete remissions 57 sustained virologic response 57 Natalizumab 57 imatinib 57 fibrinolysis 57 goserelin 57 fulvestrant 57 malignant pleural mesothelioma 56 D dimer 56 heavily pretreated 56 azacitidine 56 chronic lymphocytic leukemia CLL 56 DOXIL 56 peginterferon 56 IFN gamma 56 hepatotoxicity 56 ponatinib 56 glycemia 56 therapeutic regimens 56 superficial bladder cancer 56 pheochromocytoma 56 seroprotection 56 lactic acidosis 56 EGFR mutations 55 TORISEL 55 malignant transformation 55 platelet activation 55 serum PSA 55 nitazoxanide 55 indolent NHL 55 low dose dexamethasone 55 pharmacodynamic effects 55 nilotinib 55 XELOX 55 cytotoxic chemotherapy 55 chemoradiation 55 RRMS patients 55 serum concentrations 55 T2DM 55 serologic 55 Secondary endpoints 55 nab paclitaxel 55 KRAS mutations 55 androgen independent 55 thromboembolic events 55 genetic polymorphisms 55 chronic HBV infection 55 cerebrovascular events 54 axitinib 54 GvHD 54 neuropsychiatric symptoms 54 antithrombotic 54 lymphopenia 54 angiotensin converting enzyme inhibitors 54 rituximab 54 Fludara 54 FOLFIRI 54 systemic toxicity 54 infliximab 54 clusterin 54 liver metastases 54 vandetanib 54 intravesical 54 HCV infection 54 hyperinsulinemia 54 QTc interval 54 pathologic 54 plasma glucose 54 cytogenetic response 54 serum uric acid 54 hypomagnesemia 54 CA4P 54 TNF inhibitors 54 octreotide 54 Jevtana 54 RSD#

Back to home page